141 related articles for article (PubMed ID: 35801736)
1. Plasma exchange treats severe intrahepatic cholestasis caused by dacomitinib: A case report.
Qiao F; Chen Q; Lu W; Fang N
Medicine (Baltimore); 2022 Jul; 101(27):e29629. PubMed ID: 35801736
[TBL] [Abstract][Full Text] [Related]
2. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
3. Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib.
Qiu X; Ren B; Lian Y; Fang L; Dong Z
J Oncol Pharm Pract; 2023 Jun; 29(4):1002-1005. PubMed ID: 36380705
[TBL] [Abstract][Full Text] [Related]
4. Prolonged intrahepatic cholestasis after exposure to loxoprofen.
Ichikawa T; Sato H; Kaira K; Oh-I S; Kakizaki S; Sato K; Takagi H; Mori M
Clin Ther; 2008 Dec; 30(12):2402-6. PubMed ID: 19167598
[TBL] [Abstract][Full Text] [Related]
5. Excessive bilirubin elevation in a patient with hereditary spherocytosis and intrahepatic cholestasis.
Wree A; Canbay A; Müller-Beissenhirtz H; Dechêne A; Gerken G; Dührsen U; Lammert F; Nückel H
Z Gastroenterol; 2011 Aug; 49(8):977-80. PubMed ID: 21811948
[TBL] [Abstract][Full Text] [Related]
6. Biliary atresia combined with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Zhang BP; Huang ZH; Dong C
Medicine (Baltimore); 2019 May; 98(19):e15593. PubMed ID: 31083246
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Hepatic Impairment on the Pharmacokinetics of Dacomitinib.
Piscitelli J; Chen J; LaBadie RR; Salageanu J; Chung CH; Tan W
Clin Drug Investig; 2022 Mar; 42(3):221-235. PubMed ID: 35195881
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic cholestasis of pregnancy or azithromycin-induced intrahepatic cholestasis: A case report.
Han B; Sheng Y; Wang L; Feng H; Hou X; Li Y
Medicine (Baltimore); 2017 Dec; 96(52):e9346. PubMed ID: 29384912
[TBL] [Abstract][Full Text] [Related]
9. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
[TBL] [Abstract][Full Text] [Related]
10. A phase I open-label study to investigate the potential drug-drug interaction between single-dose dacomitinib and steady-state paroxetine in healthy volunteers.
Ruiz-Garcia A; Giri N; LaBadie RR; Ni G; Boutros T; Richie N; Kocinsky HS; Checchio TM; Bello CL
J Clin Pharmacol; 2014 May; 54(5):555-62. PubMed ID: 24293056
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced liver injury associated with dacomitinib: A case report.
Wang X; Huang A; Lu Y; Gao S; Hu W; Cheng H
Front Oncol; 2022; 12():979462. PubMed ID: 36185261
[TBL] [Abstract][Full Text] [Related]
13. The effect of dacomitinib (PF-00299804) on CYP2D6 activity in healthy volunteers who are extensive or intermediate metabolizers.
Bello CL; LaBadie RR; Ni G; Boutros T; McCormick C; Ndongo MN
Cancer Chemother Pharmacol; 2012 Apr; 69(4):991-7. PubMed ID: 22147075
[TBL] [Abstract][Full Text] [Related]
14. A rare case of acute liver failure with intrahepatic cholestasis due to dengue hemorrhagic fever: CytoSorb® and plasma exchange aided in the recovery: case report.
Gunasekera AM; Eranthaka U; Priyankara D; Kalupahana R
BMC Infect Dis; 2022 Dec; 22(1):938. PubMed ID: 36514003
[TBL] [Abstract][Full Text] [Related]
15. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
[TBL] [Abstract][Full Text] [Related]
16. Acute cholestatic hepatitis induced by fenofibrate.
Hajdu D; Aiglová K; Vinklerová I; Urbánek K
J Clin Pharm Ther; 2009 Oct; 34(5):599-602. PubMed ID: 19744016
[TBL] [Abstract][Full Text] [Related]
17. A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.
Zhou T; Xiong Q; Hong C; Wang Q; Wang W; Xu C; Cai J;
Medicine (Baltimore); 2022 Aug; 101(34):e30269. PubMed ID: 36042660
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary complications of oral contraceptives.
Lindberg MC
J Gen Intern Med; 1992; 7(2):199-209. PubMed ID: 1336797
[TBL] [Abstract][Full Text] [Related]
19. [Intrahepatic cholestasis and aplastic anemia following administration of prajmaline].
Lenzen R; Gottesbüren H; Borchard F; Wienbeck M; Strohmeyer G
Klin Wochenschr; 1988 Mar; 66(6):264-70. PubMed ID: 2452916
[TBL] [Abstract][Full Text] [Related]
20. Progressive familial intrahepatic cholestasis.
Jacquemin E
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
